Qu Xiaofei, Zhao Liqin, Zhang Ruoxin, Wei Qingyi, Wang Mengyun
Cancer institute, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Ann Transl Med. 2020 Apr;8(7):484. doi: 10.21037/atm.2020.03.54.
Although microsatellite instability (MSI) is a powerful predictive biomarker for the efficacy of immunotherapy, the mechanism of MSI in sporadic gastrointestinal cancer is not fully understood. However, epigenetics, particularly microRNAs, has been suggested as one of the main regulators that contribute to the MSI formation.
We used microRNA expression data of 386 gastric adenocarcinoma samples from The Cancer Genome Atlas (TCGA) database to identify differential microRNA expression profiles by different MSI status. We also obtained putative common target genes of the top differential microRNAs with miRanda online tools, and we analyzed these data by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes pathway enrichment (KEGG).
We found that 56 and 67 gastric adenocarcinoma samples were positive for low and high MSI, respectively, and that a high MSI status was associated with age, sex and subregion (P=0.049, 0.014 and 0.007, respectively). In the 67 samples with a high MSI status, expression levels of 14 microRNAs were upregulated but five microRNAs were downregulated as assessed by the fold change (FC), compared with that of the 56 samples with a low MSI status (P<0.05, |FC| >2). Further analysis suggested that the expression of miR-210-3p, miR-582-3p, miR-30a-3p and miR-105-5p predicted a high MSI status (P=4.93×10, 5.63×10, 3.23×10 and 7.64×10, respectively). Regulation of the transcription pathways ranked the top of lists from both GO and KEGG analyses, and these microRNAs might regulate DNA damage-repair genes that were also associated with a high MSI status.
MiR-30a-3p and miR-105-5p are potential biomarkers for the MSI-H gastric adenocarcinoma, possibly by altering expression of DNA damage-repair genes.
尽管微卫星不稳定性(MSI)是免疫治疗疗效的一种强大预测生物标志物,但散发性胃肠道癌中MSI的机制尚未完全阐明。然而,表观遗传学,特别是微小RNA,已被认为是促成MSI形成的主要调节因子之一。
我们使用来自癌症基因组图谱(TCGA)数据库的386例胃腺癌样本的微小RNA表达数据,以确定不同MSI状态下的差异微小RNA表达谱。我们还使用miRanda在线工具获得了差异最显著的微小RNA的假定共同靶基因,并通过基因本体论(GO)和京都基因与基因组百科全书通路富集(KEGG)对这些数据进行了分析。
我们发现分别有56例和67例胃腺癌样本低MSI和高MSI呈阳性,且高MSI状态与年龄、性别和亚区域相关(P分别为0.049、0.014和0.007)。在67例高MSI状态的样本中,与56例低MSI状态的样本相比,通过倍数变化(FC)评估,14种微小RNA的表达水平上调,但5种微小RNA的表达水平下调(P<0.05,|FC|>2)。进一步分析表明,miR-210-3p、miR-582-3p、miR-30a-3p和miR-105-5p的表达预测高MSI状态(P分别为4.93×10、5.63×10、3.23×10和7.64×10)。转录途径的调控在GO和KEGG分析的列表中均排名靠前,并且这些微小RNA可能调控也与高MSI状态相关的DNA损伤修复基因。
MiR-30a-3p和miR-105-5p可能是MSI-H胃腺癌的潜在生物标志物,可能是通过改变DNA损伤修复基因的表达。